Back to LLY Stock Lookup

LLY Related FDA

Jun 18, 2013 10:08 AM FDA Investigating Two Deaths Following Injection of Lilly's (LLY) Antipsychotic Zyprexa Relprevv

Jun 13, 2013 04:41 PM Lilly and Co. (LLY) Ceases BACE Phase II Voluntarily; Sees Immaterial Charge

Jun 3, 2013 08:03 AM Lilly (LLY) Says PRONOUNCE Missed Primary Superiority Endpoint

May 10, 2013 08:02 AM Lilly (LLY) to Halt Enzastaurin Production Following Phase III; Sees Charge

Apr 16, 2013 08:08 AM Lilly (LLY) Reports Dulaglutide Met Primary Endpoints in Additional Phase IIs

Mar 26, 2013 11:26 AM Boehringer, Lilly (LLY) Empagliflozin MAA Accepted by EMA

Mar 19, 2013 08:04 AM Boehringer, Lilly (LLY) Launch MARLINA Trial

Mar 14, 2013 05:43 PM FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)

Mar 7, 2013 06:43 AM Kowa, Lilly (LLY) Report LIVALO Met Primary Endpoint in Reducing LDL-C

Feb 13, 2013 04:18 PM Qiagen NV (QGEN) Enters Deal with Eli Lilly (LLY)

Feb 7, 2013 08:06 AM Eli Lilly (LLY) to Cease Tabalumab Phase 3 RA Program

Jan 15, 2013 03:39 PM Eli Lilly (LLY) Receives EC Approval of Amyvid for PET Imaging

Jan 7, 2013 11:14 AM Agilent's (A) Dako Enters Diagnostic Test Development Partnership with Lilly (LLY)

Jan 7, 2013 08:14 AM Boehringer, Lilly (LLY) Complete Four Phase 3s for Empagliflozin; Safety Profile Akin to Phase 2

Jan 7, 2013 08:13 AM Eli Lilly (LLY) Resumes Sole LY2605541 Development

Dec 20, 2012 12:45 PM Lilly (LLY) Reaches Agreement with SEC Over FCPA; Will Pay $29.4M in Settlement

Dec 13, 2012 08:04 AM Eli Lilly (LLY) to Discontinue One Tabalumab Phase 3 Study; Sees Q4 Charge

Dec 12, 2012 06:57 AM Lilly (LLY) Does Not Plan to Submit BLA for Solanezumab to FDA Following EXPEDITION Analysis

Dec 4, 2012 04:08 PM Anacor (ANAC) Achieves 2nd Candidate in Lilly (LLY) Collaboration

Nov 28, 2012 09:13 AM Par Pharma (PRX) Begins U.S. Shipments of Generic Symbyax (LLY)

Nov 14, 2012 02:33 PM Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis

Nov 8, 2012 08:45 AM Boehringer, Lilly (LLY) Completes Enrollment in CAROLINA

Oct 30, 2012 07:46 AM Lilly (LLY) Cialis Approved as BPH Treatment in Europe

Oct 22, 2012 09:08 AM Eli Lilly (LLY) Reports Phase III AWARD Met All Primary Endpoints

Oct 19, 2012 10:57 AM Lilly's (LLY) Amyvid Receives Positive CHMP Opinion in the EU

Oct 17, 2012 04:23 PM Eli Lilly (LLY) Announces Expanded Indication for ALIMTA in Certain Lung Cancers

Oct 15, 2012 08:04 AM Eli Lilly (LLY) Reports IMC-1121B Met Primary Endpoint in Phase III

Oct 8, 2012 01:18 PM Lilly (LLY) Updates on EXPEDITION in Alzheimer's; Slowing Observed in Pooled Analysis

Oct 2, 2012 06:17 AM Lilly (LLY), Boehringer Reports Significant Data from LY2605541 Phase 2 on Type 2 Diabetes

Oct 2, 2012 06:10 AM Boehringer, Lilly (LLY) Phase IIb of SGLT-2 Shows Significant Reduction in SBP

Sep 21, 2012 08:47 AM Lilly (LLY) Gets Positive Opinion from CHMP for Cialis as BPH Treatment

Sep 21, 2012 08:21 AM Eli Lilly (LLY), Boehringer Get Positive Opinion from EMA CHMP for Trajenta Type 2 Diabetes Treatment

Sep 6, 2012 09:07 AM Eli Lilly (LLY) Says POINTBREAK Phase III Missed Primary Endpoint; Did Show PFS for ALIMTA Arm

Aug 29, 2012 08:04 AM Eli Lilly (LLY) Halts Pomaglumetad Methionil Development; Sees Q3 Charge

Aug 27, 2012 01:20 PM Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); Review of Solanezumab Results

Aug 27, 2012 06:26 AM Daiichi Sankyo, Lilly (LLY) Report New TRILOGY ACS Data is Not Statistically Significant

Aug 24, 2012 08:19 AM Eli Lilly (LLY) Runs Higher as Solanezumab Found to Slow Cognitive Decline in Mild Alzheimer's Patients

Aug 24, 2012 07:01 AM Eli Lilly (LLY) Says Primary Endpoints Not Met in Two Solanezumab EXPEDITION Phase IIIs

Aug 17, 2012 02:53 PM Boehringer Ingelheim, Lilly (LLY) Receive FDA Approval for Tradjenta sNDA as Add-On to Insulin Therapy

Aug 7, 2012 09:08 AM Eli Lilly (LLY) Reports No Difference Observed Between FORTEO and Risedronate in Phase III

Jul 25, 2012 12:52 PM Canaccord Genuity Afternoon Coffee on PFE, ELN, and JNJ: I Just Forgot What I Was About to Say

Jul 25, 2012 09:27 AM Boehringer, Lilly (LLY) Receive European Marketing Approval for Jentadueto

Jul 9, 2012 06:48 AM Eli Lilly (LLY), Bristol-Myers Squibb (BMY) ERBITUX w/ FOLFIRI Granted Full-Approval by FDA

Jul 6, 2012 08:04 AM Eli Lilly (LLY) Gets Additional 6-Months of Cymbalta Pediatric Exclusivity

Jun 12, 2012 07:45 AM Lilly (LLY), Boehringer Ingelheim Report Mixed Data for LY2605541 in Type 1 and 2 Diabetes Patiets

Jun 12, 2012 07:10 AM Eli Lilly and Co. (LLY) Expands Collaboration with Novast Labs; Invests Additional $20M

Jun 11, 2012 07:21 AM Boehringer Ingelheim, Lilly (LLY) Report Encouraging Data for Empagliflozin as Add-On to Metformin in Reducing A1C Levels in Type 2 Diabetes Patients

Jun 11, 2012 07:19 AM Lilly (LLY), Boehringer Ingelheim Report Linagliptin plus ACE/ARB Post-Hoc on UACR Hits Primary Endpoint

Jun 8, 2012 10:46 AM Eli Lilly (LLY), Incyte (INCY) Achieve Primary Endpoint in Baricitinib Phase IIb as JAK Inhibitor

May 24, 2012 09:02 AM Boehringer Ingelheim, Lilly (LLY) Say Linagliptin Showed Significant Improvement in HbA1c in Phase 3

Back to LLY Stock Lookup